Overview
overview
-
Charles Dimitroff, Ph.D., is a global leader in the study of sugars, known as glycobiology, and is highly motivated to translate glycobiological findings to help cure diseases and improve the overall health of humans. His research focuses on understanding how complex sugars or âglycansâ regulate immune and cancer cell functions with the goal of developing new approaches to boost the immune system to fight diseases and to treat cancer progression. As a principal investigator for over 26 years, his efforts have helped identify the nature and impact of glycans on inflammation and cancer, while operating one of the most reputable translational glycobiology programs in the US.
Dr. Dimitroff has studied the nature of lectin â carbohydrate interactions and their impact in inflammation and cancer for the last 26 years. He has an expertise in glycobiology studies relating to tumor biology and adaptive immunity and is qualified to perform pre-clinical research investigating how glycome-related molecules contribute to the pathogenesis of inflammation and cancer. He conducts both in vitro and in vivo experiments designed to characterize the identity and function of lectins and their carbohydrate-binding ligands on leukocytes and cancer cells. -
Charles Dimitroff, Ph.D., is a global leader in the study of sugars, known as glycobiology, and is highly motivated to translate glycobiological findings to help cure diseases and improve the overall health of humans. His research focuses on understanding how complex sugars or ‘glycans’ regulate immune and cancer cell functions with the goal of developing new approaches to boost the immune system to fight diseases and to treat cancer progression. As a principal investigator for over 26 years, his efforts have helped identify the nature and impact of glycans on inflammation and cancer, while operating one of the most reputable translational glycobiology programs in the US.
Dr. Dimitroff has studied the nature of lectin – carbohydrate interactions and their impact in inflammation and cancer for the last 26 years. He has an expertise in glycobiology studies relating to tumor biology and adaptive immunity and is qualified to perform pre-clinical research investigating how glycome-related molecules contribute to the pathogenesis of inflammation and cancer. He conducts both in vitro and in vivo experiments designed to characterize the identity and function of lectins and their carbohydrate-binding ligands on leukocytes and cancer cells.
Publications
Patents issued
selected scholarly works & creative activities
-
Article
-
2025Melanoma Glycome Regulates the Pro-Oncogenic Properties of Extracellular Galectin-3. International Journal of Molecular Sciences. 26.Full Text via DOI: 10.3390/ijms26104882 Web of Science: 001496195700001
-
2024Tumor-Intrinsic Galectin-3 Suppresses Melanoma Metastasis. Journal of Investigative Dermatology. 144.Full Text via DOI: 10.1016/j.jid.2024.02.011 Web of Science: 001299876100001
-
2023Hypoxia Controls the Glycome Signature and Galectin-8-Ligand Axis to Promote Protumorigenic Properties of Metastatic Melanoma. Journal of Investigative Dermatology. 143:456-+.Full Text via DOI: 10.1016/j.jid.2022.07.033 Web of Science: 001191917600001
-
2023The pleiotropic role of galectin-3 in melanoma progression: Unraveling the enigma. Advances in Cancer Research. 157:157-193.Full Text via DOI: 10.1016/bs.acr.2022.06.001 Web of Science: 001075073400007
-
2022Inhibition of Melanoma Cell-Intrinsic Tim-3 Stimulates MAPK-Dependent Tumorigenesis. Cancer Research. 82:3774-3784.Full Text via DOI: 10.1158/0008-5472.CAN-22-0970 Web of Science: 000883828600001
-
2021Galectin-9 bridges human B cells to vascular endothelium while programming regulatory pathways. Journal of Autoimmunity. 117.Full Text via DOI: 10.1016/j.jaut.2020.102575 Web of Science: 000614250900007
-
2020Glycan characterization of pregnancy-specific glycoprotein 1 and its identification as a novel Galectin-1 ligand. Glycobiology. 30:895-909.Full Text via DOI: 10.1093/glycob/cwaa034 Web of Science: 000593026300005
-
2019I-branched carbohydrates as emerging effectors of malignant progression. Proceedings of the National Academy of Sciences of the United States of America. 116:13729-13737.Full Text via DOI: 10.1073/pnas.1900268116 Web of Science: 000474535700008
-
2018Human B Cell Differentiation Is Characterized by Progressive Remodeling of O-Linked Glycans. Frontiers in Immunology. 9.Full Text via DOI: 10.3389/fimmu.2018.02857 Web of Science: 000453354300001
-
2018Loss of GCNT2/I-branched glycans enhances melanoma growth and survival. Nature Communications. 9.Full Text via DOI: 10.1038/s41467-018-05795-0 Web of Science: 000442376200014
-
2018Galectin-9 suppresses B cell receptor signaling and is regulated by I-branching of N-glycans. Nature Communications. 9.Full Text via DOI: 10.1038/s41467-018-05770-9 Web of Science: 000441865400001
-
2016The α2,3 sialyltransferase ST3Gal1 regulates galectin-3 binding to human B cells. Journal of Immunology. 196:124.28-124.28.Full Text via DOI: 10.4049/jimmunol.196.supp.124.28
-
2015Melanoma Cell Galectin-1 Ligands Functionally Correlate with Malignant Potential. Journal of Investigative Dermatology. 135:1849-1862.Full Text via DOI: 10.1038/jid.2015.95 Web of Science: 000356180100024
-
2014Using a chimera to study the role of Galectin‐1 in immunological responses and tumor progression (LB91). The FASEB Journal. 28.Full Text via DOI: 10.1096/fasebj.28.1_supplement.lb91
-
2014Isolation and Characterization Of Chimeric Human Fc-expressing Proteins Using Protein A Membrane Adsorbers And A Streamlined Workflow. Journal of Visualized Experiments.Full Text via DOI: 10.3791/51023-v
-
2014Isolation and Characterization Of Chimeric Human Fc-expressing Proteins Using Protein A Membrane Adsorbers And A Streamlined Workflow. Journal of Visualized Experiments.Full Text via DOI: 10.3791/51023 Web of Science: 000348513500034
-
2013Human fucosyltransferase 6 enables prostate cancer metastasis to bone. British Journal of Cancer. 109:3014-3022.Full Text via DOI: 10.1038/bjc.2013.690 Web of Science: 000328646300010
-
2013Definition of Molecular Determinants of Prostate Cancer Cell Bone Extravasation. Cancer Research. 73:942-952.Full Text via DOI: 10.1158/0008-5472.CAN-12-3264 Web of Science: 000313739500052
-
2012Galectins and their ligands: negative regulators of anti-tumor immunity. Glycoconjugate Journal. 29:619-625.Full Text via DOI: 10.1007/s10719-012-9379-0 Web of Science: 000309868800007
-
2012Galectin-1 inhibits the viability, proliferation, and Th1 cytokine production of nonmalignant T cells in patients with leukemic cutaneous T-cell lymphoma. Blood. 119:3534-3538.Full Text via DOI: 10.1182/blood-2011-12-396457 Web of Science: 000302917200025
-
2012Galectin-1 Triggers an Immunoregulatory Signature in Th Cells Functionally Defined by IL-10 Expression. Journal of Immunology. 188:3127-3137.Full Text via DOI: 10.4049/jimmunol.1103433 Web of Science: 000302150300027
-
2012Metabolic Inhibition of Galectin-1-Binding Carbohydrates Accentuates Antitumor Immunity. Journal of Investigative Dermatology. 132:410-420.Full Text via DOI: 10.1038/jid.2011.335 Web of Science: 000299215500022
-
2011Peracetylated 4-Fluoro-glucosamine Reduces the Content and Repertoire of N- and O-Glycans without Direct Incorporation. Journal of Biological Chemistry. 286:21717-21731.Full Text via DOI: 10.1074/jbc.M110.194597 Web of Science: 000291464700068
-
2010Development of a Nascent Galectin-1 Chimeric Molecule for Studying the Role of Leukocyte Galectin-1 Ligands and Immune Disease Modulation. Journal of Immunology. 185:4659-4672.Full Text via DOI: 10.4049/jimmunol.1000715 Web of Science: 000282525900018
-
2009Alpha 1,3 fucosyltransferases are master regulators of prostate cancer cell trafficking. Proceedings of the National Academy of Sciences of the United States of America. 106:19491-19496.Full Text via DOI: 10.1073/pnas.0906074106 Web of Science: 000271907400049
-
2009Analysis of Physiologic E-Selectin-Mediated Leukocyte Rolling on Microvascular Endothelium. Journal of Visualized Experiments.Full Text via DOI: 10.3791/1009-v
-
2009Analysis of physiologic E-Selectin-Mediated leukocyte rolling on microvascular endothelium. Journal of Visualized Experiments.Full Text via DOI: 10.3791/1009
-
2008Analysis of glycosyltransferase expression in metastatic prostate cancer cells capable of rolling activity on microvascular endothelial (E)-selectin. Glycobiology. 18:806-817.Full Text via DOI: 10.1093/glycob/cwn070 Web of Science: 000259583900009
-
2008Vitamins A and D are potent inhibitors of cutaneous lymphocyte-associated antigen expression. Journal of Allergy and Clinical Immunology. 121:148-157.Full Text via DOI: 10.1016/j.jaci.2007.08.014 Web of Science: 000252372000022
-
2007Skin-homing receptors on effector leukocytes are differentially sensitive to glyco-metabolic antagonism in allergic contact dermatitis. Journal of Immunology. 179:8509-8518.Full Text via DOI: 10.4049/jimmunol.179.12.8509 Web of Science: 000251590000061
-
2007The 130-kDa glycoform of CD43 functions as an E-selectin ligand for activated th1 cells In Vitro and in delayed-type hypersensitivity reactions In Vivo. Journal of Investigative Dermatology. 127:1964-1972.Full Text via DOI: 10.1038/sj.jid.5700805 Web of Science: 000248591200030
-
2006Ameliorating skin-homing receptors on malignant T cells with a fluorosugar analog of N-acetylglucosamine: P-selectin ligand is a more sensitive target than E-selectin ligand. Journal of Investigative Dermatology. 126:2065-2073.Full Text via DOI: 10.1038/sj.jid.5700364 Web of Science: 000241359200019
-
2005Sharing the same vascular addressins for osteotropic behavior of hematopoietic progenitor cells and cancer. BoneKEy Reports. 2:16-19.Full Text via DOI: 10.1138/20050179
-
2005Identification of leukocyte E-selectin ligands, P-selectin glycoprotein ligand-1 and E-selectin ligand-1, on human metastatic prostate tumor cells. Cancer Research. 65:5750-5760.Full Text via DOI: 10.1158/0008-5472.CAN-04-4653 Web of Science: 000230165000036
-
2004Rolling of human bone-metastatic prostate tumor cells on human bone marrow endothelium under shear flow is mediated by E-selectin. Cancer Research. 64:5261-5269.Full Text via DOI: 10.1158/0008-5472.CAN-04-0691 Web of Science: 000223038200035
-
2003Prevention of leukocyte migration to inflamed skin with a novel fluorosugar modifier of cutaneous lymphocyte-associated antigen. Journal of Clinical Investigation. 112:1008-1018.Full Text via DOI: 10.1172/JCI200319220 Web of Science: 000185763100010
-
2003Prevention of leukocyte migration to inflamed skin with a novel fluorosugar modifier of cutaneous lymphocyte-associated antigen. Journal of Clinical Investigation. 112:1008-1018.Full Text via DOI: 10.1172/jci200319220
-
2003Glycosylation-dependent inhibition of cutaneous lymphocyte-associated antigen expression: implications in modulating lymphocyte migration to skin. Blood. 101:602-610.Full Text via DOI: 10.1182/blood-2002-06-1736 Web of Science: 000180384800034
-
2002Direct real-time observation of E- and P-selectin-mediated rolling on cutaneous lymphocyte-associated antigen immobilized on Western blots. Journal of Immunology. 168:5645-5651.Full Text via DOI: 10.4049/jimmunol.168.11.5645 Web of Science: 000175815200034
-
2001Differential L-selectin binding activities of human hematopoietic cell L-selectin ligands, HCELL and PSGL-1. Journal of Biological Chemistry. 276:47623-47631.Full Text via DOI: 10.1074/jbc.M105997200 Web of Science: 000172768500123
-
2001CD44 is a major E-selectin ligand on human hematopoietic progenitor cells. Journal of Cell Biology. 153:1277-1286.Full Text via DOI: 10.1083/jcb.153.6.1277 Web of Science: 000169318100014
-
2000A distinct glycoform of CD44 is an L-selectin ligand on human hematopoietic cells. Proceedings of the National Academy of Sciences of the United States of America. 97:13841-13846.Full Text via DOI: 10.1073/pnas.250484797 Web of Science: 000165728800070
-
2000A hematopoietic cell L-selectin ligand that is distinct from PSGL-1 and displays N-glycan-dependent binding activity. Blood. 96:2765-2774.Full Text via DOI: 10.1182/blood.V96.8.2765.h8002765_2765_2774 Web of Science: 000090003500018
-
2000A hematopoietic cell L-selectin ligand that is distinct from PSGL-1 and displays N-glycan–dependent binding activity. Blood. 96:2765-2774.Full Text via DOI: 10.1182/blood.v96.8.2765.h8002765_2765_2774
-
1999Anti-angiogenic activity of selected receptor tyrosine kinase inhibitors, PD166285 and PD173074: Implications for combination treatment with photodynamic therapy. Investigational New Drugs. 17:121-135.Full Text via DOI: 10.1023/A:1006367032156 Web of Science: 000083716200003
-
1999Cell surface N-acetylneuraminic acid α2,3-galactoside-dependent intercellular adhesion of human colon cancer cells. Biochemical and Biophysical Research Communications. 256:631-636.Full Text via DOI: 10.1006/bbrc.1999.0388 Web of Science: 000079499000033
-
1996Inhibition of human HT-29 colon carcinoma cell adhesion by a 4-fluoro-glucosamine analogue. Glycoconjugate Journal. 13:663-674.Full Text via DOI: 10.1007/BF00731455 Web of Science: A1996VC80900023
-
-
Book Chapter
-
2016Glycobiology of Human Milk in Health and Disease. 223-239.Full Text via DOI: 10.1201/b20120-12
-
-
Conference
-
2023Signature human melanoma cell surface glycans license vascular adhesion through galectin-3. Glycobiology. 1033-1033.Web of Science: 001182824100170
-
2022Glycoengineering a more effective CAR-T cell therapy. Glycobiology. 1047-1048.Web of Science: 000878249700190
-
2021Microenvironmental and intracellular galectin-3 govern melanoma progression. Glycobiology. 1689-1689.Web of Science: 000754737200035
-
2021hypoxia controls the glycobiological signature and related pro-tumorigenic properties of metastatic melanomas. Glycobiology. 1683-1684.Web of Science: 000754737200024
-
2021Abstract 2609: Hypoxia-mediated downregulation of GCNT2/I-antigen in metastatic melanoma accelerates disease progression and mortality. Cancer Research. 2609-2609.Full Text via DOI: 10.1158/1538-7445.am2021-2609
-
2021Hypoxia-mediated downregulation of GCNT2/I-antigen in metastatic melanoma accelerates disease progression and mortality.. Cancer Research.Web of Science: 000680263507006
-
2020GCNT2 suppression in metastatic melanoma is potentiated by hypoxia and correlates with aggressive disease progression. Glycobiology. 1041-1041.Web of Science: 000606577100049
-
2020Galectin-9 helps govern human B cell adhesion to and migration through human vascular endothelium.. Glycobiology. 1071-1071.Web of Science: 000606577100109
-
2016I-branched N-glycans Negatively Regulate Melanoma Growth and Insulin-like Growth Factor Receptor Signaling. Glycobiology. 1383-1384.Web of Science: 000392935600027
-
2016ST3Gal1 truncates O-glycans and augments galectin-3 binding to CD45 in human B cells. Glycobiology. 1486-1486.Web of Science: 000392935600276
-
2016Structural characterization of the N-glycome from malignant melanoma cells reveals galectin ligands. Glycobiology. 1442-1443.Web of Science: 000392935600170
-
2016"I"-branched Carbohydrates Negatively Regulate Galectin-3-binding and Melanoma Malignancy. Journal of Immunology.Web of Science: 000380288302174
-
2016The alpha 2,3 sialyltransferase ST3Gall regulates galectin-3 binding to human B cells. Journal of Immunology.Web of Science: 000380288300086
-
2015Human germinal center B cells express a unique glycosylation signature characterized by poly-N-acetyllactosaminyl glycans. Glycobiology. 1250-1251.Web of Science: 000362991500064
-
2014Using a chimera to study the role of Galectin-1 in immunological responses and tumor progression. The FASEB Journal.Web of Science: 000346651005202
-
2012Galectin-1 can bind human melanoma-specific CD8+T cells and trigger immunosuppression. Journal of Investigative Dermatology. S101-S101.Web of Science: 000302866900596
-
2012How To Build "Lean and Mean" Anti-Tumor T Cells: A Strategic View into the Anti-Carbohydrate Action of Fluorinated Glucosamine Analogs. ACS Symposium Series. 123-135.Web of Science: 000316091100007
-
2011Blocking galectin-1 ligand biosynthesis enhances immunity against melanoma. Journal of Investigative Dermatology. S96-S96.Web of Science: 000289035600575
-
2011Dimeric galectin-1 alters the plasticity and commitment of Th1 and Th17 cells by promoting IL-10 expression. Journal of Immunology.Web of Science: 000209751706077
-
2010Abstract 5178: Homing of circulating prostate cancer cells to bone is regulated by alpha 1,3 fucosyltransferase 7. Cancer Research. 5178-5178.Full Text via DOI: 10.1158/1538-7445.am10-5178
-
2010Galectin-1 is a potent inducer of a regulatory phenotype on skin-resident memory T cells. Journal of Investigative Dermatology. S113-S113.Web of Science: 000276455100672
-
2009Intravascular rolling of prostate cancer cells is elaborated by alpha 1,3 fucosyltransferase activity. Clinical and Experimental Metastasis. 861-861.Web of Science: 000271722300060
-
2009CARB 110-Dissecting the glycobiologic regulators of prostate tumor metastasis. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY.Web of Science: 000207861902033
-
2007Molecular analysis of skin-homing receptors on natural killer cells associated with allergic contact dermatitis. Journal of Investigative Dermatology. S115-S115.Web of Science: 000245387800684
-
2006Identifying a novel skin-homing receptor on inflammatory lymphocytes. Journal of Investigative Dermatology. 121-121.Web of Science: 000242891500720
-
2006Vitamin A and D derivatives block cutaneous lymphocyte-associated antigen expression on human T cells via selective glycosyltransferase inhibition. Journal of Investigative Dermatology. 123-123.Web of Science: 000242891500731
-
2005Downregulation of cutaneous lymphocyte-associated antigen and E-selectin ligand activity on malignant skin-homing T cells with the fluorosugar, 4-fluoro-n-acetylglucosamine. Journal of Investigative Dermatology. A32-A32.Web of Science: 000228179900188
-
2004Expression of cutaneous lymphocyte-associated antigen on human bone-metastatic prostate tumor cells. Journal of Investigative Dermatology. A30-A30.Web of Science: 000220660500231
-
2003CD44/HCELL is an E- and L-selectin ligand on murine hematopoietic progenitor cells.. Blood. 180B-180B.Web of Science: 000186537100725
-
2002Functional modulation of cutaneous lymphocyte-associated antigen on skin-homing lymphocytes and prevention of allergic contact dermatitis with a fluorinated analog of N-acetylglucosamine. Journal of Investigative Dermatology. 342-342.Web of Science: 000177428100801
-
2002Expression of selectin ligands on blasts from human acute leukemias. Experimental Hematology. 81-81.Web of Science: 000176187000177
-
2001Homing and hematopoiesis: HCELL is the principal E-selectin and L-selectin ligand of human hematopoietic stem cells.. Blood. 710A-710A.Web of Science: 000172134102980
-
2001Direct observation of E-selectin mediated rolling on cutaneous lymphocyte-associated antigen using a novel blot rolling assay. Journal of Investigative Dermatology. 397-397.Web of Science: 000170668300079
-
1999Novel L-selectin ligand activity with unique biophysical characteristics on hematopoietic progenitor cells.. Blood. 255A-255A.Web of Science: 000083790301181
-
-
Other Scholarly Work
-
2023The metastasis-suppressive function of intracellular galectin-3 in melanoma. Cancer Research.Full Text via DOI: 10.1158/1538-7445.AM2023-3602 Web of Science: 001008499101086
-
2023Collaborative Spirit Drives the Field of Tumor Glycobiology: A Preface to Special Volume on Cancer Glycobiology. Advances in Cancer Research. XV-XVI.Full Text via DOI: 10.1016/S0065-230X(23)00010-6 Web of Science: 001075073400001
-
2022Analysis of Galectin-Binding Receptors on B Cells. Methods in molecular biology (Clifton, N.J.). 565-580.Full Text via DOI: 10.1007/978-1-0716-2055-7_30
-
2019Cancer immunotherapy needs to learn how to stick to its guns. Journal of Clinical Investigation. 5089-5091.Full Text via DOI: 10.1172/JCI133415 Web of Science: 000500567600011
-
2012Evidence of a novel galectin-9-binding membrane glycoprotein ligand on T helper cells. Clinical Immunology. 6-7.Full Text via DOI: 10.1016/j.clim.2012.01.010 Web of Science: 000301908800003
-
2007A novel adhesion molecule plays a critical role in T cell migration to inflamed skin. Journal of Allergy and Clinical Immunology. S161-S161.Full Text via DOI: 10.1016/j.jaci.2006.11.570 Web of Science: 000251460401019
-
2000A new method for identification of adhesive interactions under shear force conditions. Experimental Hematology. 35-35.Full Text via DOI: 10.1016/S0301-472X(00)00198-3 Web of Science: 000088004200014
-
-
Review
-
2024Galectin-9-ligand axis: an emerging therapeutic target for multiple myeloma. Frontiers in Immunology.Full Text via DOI: 10.3389/fimmu.2024.1469794 Web of Science: 001328707300001
-
2024The role of galectins in mediating the adhesion of circulating cells to vascular endothelium. Frontiers in Immunology.Full Text via DOI: 10.3389/fimmu.2024.1395714 Web of Science: 001238251200001
-
2023Galectins can serve as biomarkers in COVID-19: A comprehensive systematic review and meta-analysis. Frontiers in Immunology.Full Text via DOI: 10.3389/fimmu.2023.1127247 Web of Science: 000948744000001
-
2022Decoding Strategies to Evade Immunoregulators Galectin-1,-3, and-9 and Their Ligands as Novel Therapeutics in Cancer Immunotherapy. International Journal of Molecular Sciences.Full Text via DOI: 10.3390/ijms232415554 Web of Science: 000902497000001
-
2021Melanoma-associated glycosyltransferase GCNT2 as an emerging biomarker and therapeutic target. British Journal of Dermatology. 294-301.Full Text via DOI: 10.1111/bjd.19891 Web of Science: 000646549800001
-
2018Galectin-Glycan Interactions as Regulators of B Cell Immunity. Frontiers in Immunology.Full Text via DOI: 10.3389/fimmu.2018.02839 Web of Science: 000452075100001
-
2015Galectin-Binding O-Glycosylations as Regulators of Malignancy. Cancer Research. 3195-3202.Full Text via DOI: 10.1158/0008-5472.CAN-15-0834 Web of Science: 000359562100001
-
2013Leveraging fluorinated glucosamine action to boost antitumor immunity. Current Opinion in Immunology. 206-213.Full Text via DOI: 10.1016/j.coi.2012.11.003 Web of Science: 000319369100013
-
2012Galectin-1 research in T cell immunity: Past, present and future. Clinical Immunology. 107-116.Full Text via DOI: 10.1016/j.clim.2011.09.011 Web of Science: 000300388200005
-
2007Targeting selectins and selectin ligands in inflammation and cancer. Expert Opinion on Therapeutic Targets. 1473-1491.Full Text via DOI: 10.1517/14728222.11.11.1473 Web of Science: 000251116800008
-
1998Cancer metastasis: A search for therapeutic inhibition. Cancer Investigation. 279-290.Full Text via DOI: 10.3109/07357909809039778 Web of Science: 000073297400010
-
Research
principal investigator on
- Analysis of galectin-8 and its ligands in melanoma progression awarded by National Cancer Institute 2024 - 2029
- Cell type-directed Tim-3 targeting in melanoma awarded by National Institutes of Health 2022 - 2026
- Designing a more effective CAR-T cell treatment against diffuse large B cell lymphoma awarded by Baptist Health South Florida 2025 - 2026
- Functional analysis of a novel integrin-dependent metastasis pathway in melanoma awarded by National Cancer Institute 2020 - 2025
- Janssen 2024 SODEP scholar selections awarded by Janssen 2024 - 2025
- Analysis of Glycomic Regulators in Melanoma Progression awarded by National Cancer Institute 2019 - 2025
- The metastasis-suppressive function of intracellular galectin-3 in melanoma awarded by Sigma Xi 2023
- Analysis of novel biomarkers of melanoma metastasis awarded by Everest Foundation 2021 - 2023
- Baptist Lab Support awarded by Baptist Health South Florida 2016 - 2022
- Impact of Human Melanoma Glycome on Immune Evasion awarded by Melanoma Research Foundation 2021 - 2022
- Analysis of vascular Galectin-9 as an immunomodulator of B-cell activity awarded by Allergy and Infectious Diseases 2019 - 2021
- Forging Translational Glycobiologists: Intermeshing Glycoscience Training and Clinical Education awarded by National Institutes of Health 2020 - 2021
- Functional Analysis of Human Endothelial Cell Galectin-9 on Human B cells awarded by Brigham and Women's Hospital 2019 - 2020
subproject principal investigator on
investigator on
Contact
full name
- Charles Dimitroff
